Grown Rogue International (GRUSF) Return on Invested Capital (2020 - 2026)
Grown Rogue International's (GRUSF) quarterly Return on Invested Capital came in at 6501436220.61% in Q1 2026, down 2695080753490.86% quarter-over-quarter from 0.24% in Q4 2023.
Grown Rogue International (GRUSF) Return on Invested Capital (2020 - 2026) Analysis & Trends
Grown Rogue International's Return on Invested Capital history runs 3 years deep, the most recent figure standing at 6501436220.61% for Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROIC (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 0.01% |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 0.01% |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 0.00% |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 0.00% |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 0.03% |
| 10 | Grown Rogue International | 99.97 Mn | 92.67 Mn | 3.96 Mn | -6,501,436,220.61% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -6,501,436,220.61% |
| Dec 31, 2023 | -0.24% |
| Jan 31, 2020 | -0.01% |